ES2033525T3 - Mejoras en o relativas a derivados de propanamina. - Google Patents

Mejoras en o relativas a derivados de propanamina.

Info

Publication number
ES2033525T3
ES2033525T3 ES198989303401T ES89303401T ES2033525T3 ES 2033525 T3 ES2033525 T3 ES 2033525T3 ES 198989303401 T ES198989303401 T ES 198989303401T ES 89303401 T ES89303401 T ES 89303401T ES 2033525 T3 ES2033525 T3 ES 2033525T3
Authority
ES
Spain
Prior art keywords
propanamine derivatives
propanamine
derivatives
substitutedphenoxy
propanamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989303401T
Other languages
English (en)
Inventor
David Wayne Robertson
David Taiwai Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2033525T3 publication Critical patent/ES2033525T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/16—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C317/22—Sulfones; Sulfoxides having sulfone or sulfoxide groups and singly-bound oxygen atoms bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/23—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/24—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
    • C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA 3 - (FENOXI - 4 - SUSTITUIDO) 3 - FENIL - PROPANOAMINAS CAPACES DE INHIBIR LA ABSORCION DE SEROTONINA.
ES198989303401T 1988-04-08 1989-04-06 Mejoras en o relativas a derivados de propanamina. Expired - Lifetime ES2033525T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17936888A 1988-04-08 1988-04-08

Publications (1)

Publication Number Publication Date
ES2033525T3 true ES2033525T3 (es) 1993-03-16

Family

ID=22656301

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989303401T Expired - Lifetime ES2033525T3 (es) 1988-04-08 1989-04-06 Mejoras en o relativas a derivados de propanamina.

Country Status (19)

Country Link
EP (1) EP0336753B1 (es)
JP (1) JPH0285236A (es)
KR (1) KR890015995A (es)
CN (1) CN1036562A (es)
AT (1) ATE78029T1 (es)
AU (1) AU611794B2 (es)
CA (1) CA1337128C (es)
DE (1) DE68901994T2 (es)
DK (1) DK165489A (es)
ES (1) ES2033525T3 (es)
GR (1) GR3005662T3 (es)
HU (1) HU205344B (es)
IE (1) IE891122L (es)
IL (1) IL89854A (es)
NZ (1) NZ228636A (es)
PH (1) PH27144A (es)
PT (1) PT90212B (es)
SU (1) SU1750421A3 (es)
ZA (1) ZA892517B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK630987D0 (da) * 1987-12-01 1987-12-01 Ferrosan As Aryloxyphenylpropylaminer, deres fremstilling og anvendelse
CA2042346A1 (en) * 1990-05-17 1991-11-18 Michael Alexander Staszak Chiral synthesis of 1-aryl-3-aminopropan-1-ols
DK0537915T3 (da) * 1991-09-27 1995-11-27 Lilly Co Eli N-alkyl-3-phenyl-3-(2-alkylthiophenoxy)propylaminer som inhibitorer for epinephrin
US5281624A (en) * 1991-09-27 1994-01-25 Eli Lilly And Company N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof
EP0576766A1 (en) * 1992-06-29 1994-01-05 Novo Nordisk A/S Propanolamine derivatives, their preparation and use
IL110857A0 (en) * 1993-09-09 1994-11-28 Lilly Co Eli Cessation of tobacco use
US5936124A (en) * 1998-06-22 1999-08-10 Sepacor Inc. Fluoxetine process from benzoylpropionic acid
US6025517A (en) * 1998-08-03 2000-02-15 Sepracor Inc. Fluoxetine process from benzoylacetonitrile
ITMI20061987A1 (it) * 2006-10-16 2008-04-17 Archimica Srl Processo per la sintesi di arilossipropilammine ed eteroarilossipropilammine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4243681A (en) * 1977-10-11 1981-01-06 Mead Johnson & Company Alkylthiophenoxypropanolamines and pharmaceutical compositions and uses thereof
US4147805A (en) * 1978-07-28 1979-04-03 Mead Johnson & Company Alkylthiophenoxyalkylamines and the pharmaceutical use thereof
GB2060622B (en) * 1979-09-14 1983-05-25 Wyeth John & Brother Ltd 3-aryl-3-aryloxyalkylamines
US4569801A (en) * 1984-10-15 1986-02-11 Eli Lilly And Company Alkylsulfonamidophenylalkylamines

Also Published As

Publication number Publication date
AU611794B2 (en) 1991-06-20
PH27144A (en) 1993-04-02
ZA892517B (en) 1990-12-28
IE891122L (en) 1989-10-08
NZ228636A (en) 1990-12-21
DK165489D0 (da) 1989-04-06
IL89854A (en) 1994-02-27
AU3252889A (en) 1989-10-12
EP0336753B1 (en) 1992-07-08
DE68901994T2 (de) 1993-02-25
CA1337128C (en) 1995-09-26
HU205344B (en) 1992-04-28
PT90212A (pt) 1989-11-10
DK165489A (da) 1989-10-09
JPH0285236A (ja) 1990-03-26
SU1750421A3 (ru) 1992-07-23
KR890015995A (ko) 1989-11-27
EP0336753A1 (en) 1989-10-11
HUT54976A (en) 1991-04-29
PT90212B (pt) 1994-06-30
ATE78029T1 (de) 1992-07-15
DE68901994D1 (de) 1992-08-13
GR3005662T3 (es) 1993-06-07
CN1036562A (zh) 1989-10-25

Similar Documents

Publication Publication Date Title
DE68907659D1 (de) Warmhaertende organosiloxanzusammensetzung.
FI895952A0 (fi) Transparenta propylenpolymerkompositioner med foerbaettrad slaghaollfasthet.
DE68902305T2 (de) Schmierfilmzusammensetzung.
DE68913531D1 (de) Kalziumhypochloritzusammensetzung.
DE68916395T2 (de) Zusammensetzung.
IT1203945B (it) Agenti stabilizzanti costituiti da 1,3,2-ossazafosfolidine
DE68924246D1 (de) Tonerzusammensetzung.
NO900305D0 (no) Sjoe-seismisk kilde.
DE68911577D1 (de) Polyketonzusammensetzung.
ES2033525T3 (es) Mejoras en o relativas a derivados de propanamina.
NO177193C (no) Kjörbar sporpakkemaskin
DE68906193T2 (de) Hypersphyxia verursachende zusammensetzung.
DE68920622T2 (de) Polyketonzusammensetzungen.
DE68903729D1 (de) Tertiaere thiolaethoxylat-zusammensetzung.
FI892552A (fi) Benzoyl- och ketonperoxidkomposition.
DE58907784D1 (de) Zusammensetzung eines Mikrokontrollers.
DE68922713D1 (de) Orthopädischer Sohlenrohling.
DE68916142D1 (de) Zusammensetzung.
DE68909455D1 (de) Polyaethylen-zusammensetzung.
DE3854389D1 (de) Absoluter Kodierer des Multiumlaufstyps.
BR8604423A (pt) Componente eletromecanico ajustavel por rotacao
ES1007017Y (es) Juego de composicion.
DE68916171D1 (de) Keimtötende Zusammensetzung.
ATE88637T1 (de) Hypersphyxia verursachende zusammensetzung.
DE68921240T2 (de) Unempfindlichmachende Zusammensetzung.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 336753

Country of ref document: ES